GOVX

$0.16+0.67%visit website

GeoVax Labs, Inc.

Market Cap

$1M

Live price × SEC shares (Jul 27, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

3.86

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.7

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	0.00	0.00	0.00	0.00	0.00
Research & development	5,044	2,994	3,903	3,111	15,052
Total operating expenses	6,373	4,442	5,273	4,442	20,530
Operating income	(6,373)	(4,442)	(5,273)	(4,442)	(20,530)
Interest expense	0.00	0.00
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(6,319)	(4,418)	(5,262)	(4,427)	(20,426)
EPS (basic) ($)	(0.31)		(2.62)	(0.97)	—
Weighted avg. shares (basic)	20,287		2,008	4,565

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Jul 27, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

18 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Oct 27, 2026 accepted 1:00 PM ET	5.07Shareholder vote	Document SEC ↗
Oct 27, 2026 accepted 9:00 AM ET	1.01Material agreement2.03New debt obligation3.03Holder rights modified5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Sep 10, 2026 accepted 4:35 PM ET	8.01Other events	Document SEC ↗
Aug 28, 2026 accepted 4:16 PM ET	3.01Delisting notice	Document SEC ↗
Aug 28, 2026 accepted 4:09 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Jul 27, 2026 accepted 4:33 PM ET	2.02Earnings release	Document SEC ↗
Jul 10, 2026 accepted 4:04 PM ET	3.01Delisting notice	Document SEC ↗
Jun 17, 2026 accepted 4:32 PM ET	5.07Shareholder vote	Document SEC ↗
May 19, 2026 accepted 5:04 PM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
May 14, 2026 accepted 4:23 PM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

18%

W/W -3.7pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

GeoVax Labs Inc (NASDAQ: GOVX) Share Price, GOVX Stock News, GOVX Share Price & Updates

kalkine.ca · 2026-11-02

GeoVax Labs (GOVX) Cash Flow Statement

Moomoo · 2026-11-02

Update - GeoVax Enters Into $1 Million Revolving Loan Agreement

Yahoo · 2026-10-27

GeoVax Enters Into $1 Million Revolving Loan Agreement

Yahoo · 2026-10-26

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga · 2026-10-22

Curious about the stocks that are showing activity after the closing bell on Tuesday?

ChartMill · 2026-10-06

GeoVax to Highlight Next-Generation MVA Vaccine and Manufacturing Advances at World Vaccine Congress Europe 2026

Yahoo · 2026-10-06

What's going on in today's pre-market session

ChartMill · 2026-10-06

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 2026-10-06

Why Option Care Health Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket

Benzinga · 2026-10-06

These stocks are moving in today's after hours session

ChartMill · 2026-10-05

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga · 2026-10-05

GeoVax Highlights Likely Sustained Clade Ib Mpox Transmission in the United States

Yahoo Finance · 2026-09-29

GeoVax Next-Generation MVA Vaccine Demonstrates Durable Single-Dose Protection in Preclinical Models

Yahoo Finance · 2026-09-21

GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial

Yahoo Finance · 2026-09-14

Informational purposes only, not investment advice.

Corporate Events (8-K)

18 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Oct 27, 2026 accepted 1:00 PM ET	5.07Shareholder vote	Document SEC ↗
Oct 27, 2026 accepted 9:00 AM ET	1.01Material agreement2.03New debt obligation3.03Holder rights modified5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Sep 10, 2026 accepted 4:35 PM ET	8.01Other events	Document SEC ↗
Aug 28, 2026 accepted 4:16 PM ET	3.01Delisting notice	Document SEC ↗
Aug 28, 2026 accepted 4:09 PM ET	1.01Material agreement3.02Unregistered equity sale	Document SEC ↗
Jul 27, 2026 accepted 4:33 PM ET	2.02Earnings release	Document SEC ↗
Jul 10, 2026 accepted 4:04 PM ET	3.01Delisting notice	Document SEC ↗
Jun 17, 2026 accepted 4:32 PM ET	5.07Shareholder vote	Document SEC ↗
May 19, 2026 accepted 5:04 PM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
May 14, 2026 accepted 4:23 PM ET	2.02Earnings release	Document SEC ↗

GOVX

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

GeoVax Labs, Inc. (GOVX)

Factor Profile

Corporate Events (8-K)